Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi

Showing 15 posts of 579 posts found.

Sanofi under investigation for anti-competitive practices

May 20, 2010
Sales and Marketing Plavix, Sanofi

Sanofi-Aventis is to be investigated by the French Competition Authority for anti-competitive practices, following allegations it prevented the launch of …

News

Sanofi-Aventis signs drug with potential to reverse diabetes

April 9, 2010
Research and Development Sanofi, diabetes

Sanofi-Aventis has signed a deal with a US biotech firm to develop a new treatment which could restore patients’ ability …

News

Warner Chilcott gets Actonel lift

April 6, 2010
Sales and Marketing Sanofi, Warner Chilcott, actonel, osteoporosis

Warner Chilcott has assumed all commercial responsibility for its osteoporosis drug Actonel in the US. Sanofi-Aventis has agreed to pass …

News

Sanofi and Merck to merge animal health businesses

March 9, 2010
Sales and Marketing Merck, Sanofi, animal health

Sanofi-Aventis and Merck have announced a joint venture, bringing together their animal health businesses Merial and Intervet/Schering-Plough.  The company’s say …

News

Sanofi’s BSI-201 tipped for success in triple negative breast cancer

February 28, 2010
Sales and Marketing Cancer, PARP, Sanofi, breast cancer

 Sanofi-Aventis’s BSI-201 will garner sales of $1.7 billion in the triple negative breast cancer drug market in 2018, according to …

News

Lancet retracts MMR research conclusions

February 3, 2010
Research and Development MMR, Sanofi, vaccines

The Lancet, the journal which originally published the controversial research linking the MMR vaccine to autism has issued a full …

News

Sanofi Pasteur collaborates on novel biologics

January 12, 2010
Research and Development KaloBios, Sanofi, Sanofi Pasteur, cystic fibrosis, infection, vaccines

Sanofi Aventis’ vaccines division has partnered with US biotech KaloBios to develop a number of novel biologic treatments. Sanofi Pasteur …

News

NICE says no to Multaq

January 8, 2010
Sales and Marketing Multaq, NICE, Sanofi

NICE has rejected Sanofi-Aventis’ new anti-blood clot treatment Multaq (dronedarone) for use on the NHS because of its cost. According …

News

Sanofi bags consumer healthcare specialist Chattem

January 5, 2010
Chattem, OTC, Sanofi

Sanofi-Aventis looks set to become much bigger in over-the-counter pharmaceuticals with a $1.9 billion agreement to buy US company Chattem. …

News
Sanofi-Aventis manufacturing facility in Dagenham

Sanofi pulls out of Dagenham

December 21, 2009
Manufacturing and Production Essex, Sanofi, closure

The UK stands to lose one of its flagship pharmaceutical manufacturing facilities with the recent announcement that Sanofi-Aventis’ site in …

News

Sanofi’s Plavix combination recommended for European approval

December 21, 2009
Research and Development, Sales and Marketing DuoPlavin, Plavix, Sanofi, cabazitaxel, eplivanserin, idrabiotaparinux

Sanofi-Aventis has received the backing of a key European regulatory committee for its cardiology treatment DuoPlavin, which combines its blockbuster …

News
logo

Sanofi expands antibody venture with Regeneron

November 12, 2009
Research and Development Regeneron, Sanofi

 Sanofi-Aventis has put more financial muscle behind its partnership with Regeneron for the development of monoclonal antibody-based drugs, boosting its …

News

Sanofi says its H1N1 jab effective after one dose

October 2, 2009
Sales and Marketing Sanofi, h1n1

 Sanofi Pasteur, the vaccines division of the Sanofi-Aventis Group, has said its swine flu vaccine is effective after a single …

News

Sanofi-Aventis acquires French biotech Fovea

October 1, 2009
Sales and Marketing Sanofi, ophth

 Sanofi-Aventis is to acquire Fovea Pharmaceuticals, a privately held French company with a focus on diseases of the eye.Fovea has …

News

Sanofi on track to deliver flu vaccine

September 30, 2009
Sales and Marketing Sanofi, h1n1

French company Sanofi-Pasteur is on track to deliver its H1N1 flu vaccine over the next two months, chief executive Chris …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025